GALMED PHARMACEUTICALS LTD. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
GALMED PHARMACEUTICALS LTD. (GLMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 2.78 thousand shares for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-18.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2021-03-18
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month as first filed |
|---|---|---|
| 2020-12-31 | 2.78K shares 20-F · filed 2021-03-18 | |
| 2019-12-31 | 56.75K shares 20-F · filed 2021-03-18 | 54.32K shares 20-F · filed 2020-03-12 |
| 2018-12-31 | 41.46K shares 20-F · filed 2020-03-12 | 45.31K shares 20-F · filed 2019-03-13 |
| 2017-12-31 | 30.93K shares 20-F · filed 2019-03-13 | |
| 2016-12-31 | 78.75K shares 20-F · filed 2021-03-18 |